L3VLUP
ProSign in

EYPT in the 13F filings

Eyepoint Pharmaceuticals Inc · CUSIP 30233G209

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q2 2026Q1 2026Q4 2025Q3 2024Q1 2024Q4 2023Q2 2023Q3 2022Q2 2022Q1 2022Q4 2021
Quarter end
30 Sep 2022
the date the book describes
Filed
14 Nov 2022
up to 45 days after the quarter end
Managers listing it
1
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q2 2022 and Q3 2022; 1 listed it in both
Shares listed
564,551
combined, among listed positions
Reported value
$4.5m
combined, at the quarter end

Managers listing EYPT in Q3 2022

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2022, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

1 of 1 holder

ActionFiling
Verition Fund Management LLC564,551$4.5munder 0.1%Added+26,98214 Nov 2022 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2022 to Q3 2022, among managers that listed it in both quarters or opened it.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q3 2022 to 1 in Q2 2026

Tracked managers listing it, at least.

0123Q4 2021Q1 2022Q2 2022Q3 2022Q2 2023Q4 2023Q1 2024Q3 2024Q4 2025Q1 2026Q2 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
EYPT by quarter
QuarterHoldersReported valueBuyersSellers
Q4 20211$3.9mn.a.n.a.
Q1 20222$18mn.a.n.a.
Q2 20221$4.2mn.a.n.a.
Q3 20221$4.5mn.a.n.a.
Q2 20231$3.3mn.a.n.a.
Q4 20231$9.2m10
Q1 20241$9.9m10
Q3 20241$3.2m10
Q4 20253$76m146
Q1 20262$52m148
Q2 20261$54m139

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

EYPT and LLY →EYPT and JNJ →EYPT and VRTX →Choose a stock to compare with EYPT →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own EYPT, latest filings →Back to the 13F Explorer →